U.S. Marine and Shipping Stock News

In recent days, Rambam Health Care Campus, EOS GmbH, and PTC Inc. established a Digital Implant Engineering Center in Haifa and PTC also launched its Onshape Labs early-access AI program while deepening PLM partnerships such as with Whatfix, all alongside recognition in Gartner’s 2026 Magic Quadrant for PLM Software. This cluster of healthcare, AI-CAD, and PLM adoption initiatives highlights how PTC’s software is being embedded directly into customers’ critical engineering and clinical...

International Paper recently announced it will permanently close its Carrollton South packaging facility in Carrollton, Texas by the end of the third quarter of 2026 as part of efforts to better align its manufacturing footprint with customer demand in North America. The move underscores how International Paper is reshaping its plant network, reallocating resources, and offering severance, continued benefits, outplacement support, and potential redeployment for nearly all 64 affected...

In recent days, DoubleVerify Holdings highlighted slower revenue growth and ongoing fee pressure for 2026, while guiding to adjusted EBITDA margins around 34% and continuing to leverage its debt‑free balance sheet and share repurchases to fund AI and product expansion. At the same time, DoubleVerify is rapidly broadening its reach in social media, connected TV, and AI-driven verification tools, aiming to offset pressure in its core business by tapping newer ad formats where monetization and...

In early July 2026, Aduna announced a nationwide Number Verification solution, developed with AT&T, T-Mobile US, and Verizon, to strengthen mobile identity protection and reduce AI-driven fraud risks for U.S. smartphone users. This carrier-level collaboration positions T-Mobile at the core of an industry-wide security upgrade that could make mobile logins both safer and smoother for millions of customers. Next, we’ll explore how T-Mobile’s role in this cross-carrier fraud reduction...

Whistleblower claims that Alignment Healthcare (ALHC) misclassified operating expenses as capital expenditures, allegedly inflating reported financial metrics, have prompted investigations by multiple law firms and put the stock and its accounting practices under closer scrutiny. See our latest analysis for Alignment Healthcare. Alignment Healthcare’s share price has come under pressure in the short term, with 1 day, 7 day and 90 day share price returns all declining. However, the 1 year...

Grupo Aeroméxico, S.A.B. de C.V. ( NYSE:AERO ) shareholders are probably feeling a little disappointed, since its...

Fastenal Company ( NASDAQ:FAST ) came out with its quarterly results last week, and we wanted to see how the business...

Newell Brands (NWL) has drawn investor attention after recent share price moves, with the stock closing at $5.43. That places the company’s market value near $2.31 billion and is prompting fresh questions about valuation. See our latest analysis for Newell Brands. The recent 1 day share price return of 5.23% adds to a 90 day share price return of 25.40% and a year to date share price return of 45.97%, while the 5 year total shareholder return has declined 74.83%. This combination indicates...

A sharp escalation in U.S. and Iran tensions, wider strikes across the region, and an 11% weekly jump in Brent and WTI futures have quickly reshaped the risk and return trade off around oil and gas. When the Strait of Hormuz and broader Middle East supply routes face higher disruption risk, some companies exposed to this news may see new opportunities while others confront added uncertainty and cost. This article walks through three stocks from the Energy Sector, Oil & Gas Producers screener...

Legend Biotech (NasdaqGS:LEGN) is in focus after reporting that CARVYKTI® generated about US$657 million in net trade sales for the quarter ended June 30, 2026, based on figures provided by partner Janssen. See our latest analysis for Legend Biotech. Despite the CARVYKTI® sales update, Legend Biotech’s share price has been under pressure in the short term, with a 7 day share price return down 17.06% and a 30 day share price return down 31.97%, while the 1 year total shareholder return is down...

Clearway Energy has delivered a 56.6% total return over the past 5 years, yet its current checks still lean on the cheap side, which raises the question of whether the recent share price around US$33.77 is fully reflecting the underlying cash generation and risks. A 56.6% return over 5 years suggests Clearway Energy has already rewarded patient investors, so any further upside may depend on how much value is still not priced in. The build out of renewable and storage assets tied to long term...

Charter Communications stock has had a tough run over the last few years, yet its valuation checks currently lean cheap. This sets up a clear tension between the share price slide and what the broader metrics imply about value. Over the past 5 years, Charter Communications has declined about 81.5%, which means long term holders have seen a substantial erosion in market value. For today’s valuation, the key support is whether the core subscription and broadband cash flows can remain...

Enphase Energy stock is caught between mixed valuation signals, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to today’s price while market based multiples screen as more supportive, all against a five year share price record that has been heavily negative. Over the last 5 years, Enphase Energy has delivered a share price decline of 77.0%, which sets a cautious backdrop for any valuation case today. On the upside, new products such as the IQ9N...

In the days leading up to its 22 July 2026 earnings release, GE Vernova drew attention as analysts pointed to strong anticipated second‑quarter results supported by AI data center–driven power demand and a growing backlog in its Power and Electrification segments, even as the Wind business continued to face project delays and supply‑chain issues. An interesting angle is GE Vernova’s decision to commit US$11 billion to capital expenditure and R&D through 2028 to capture AI‑related power and...

UnitedHealth Group (UNH) is back in focus after reporting second quarter results that beat expectations on revenue and adjusted earnings, lifting full year profit guidance and sending the stock sharply higher. See our latest analysis for UnitedHealth Group. The latest jump in UnitedHealth Group’s share price comes on top of a 30.42% 90 day share price return and a 50.91% total shareholder return over the past year. This suggests momentum has rebuilt after the 2025 setback, and the recent...

In July 2026, Arovella Therapeutics announced a collaboration under which Charles River Laboratories International will provide GMP Next Generation Sequencing services for iNKT cell characterization and viral safety testing to support ALA-101, an off-the-shelf CAR-iNKT therapy targeting CD19+ B cell cancers. This partnership, combined with Charles River’s recent acquisition of NGS specialist Pathoquest, underscores its push into higher-value sequencing-based testing for cell and gene...

Lenivia launch puts Zoetis stock back on investors’ radar Zoetis (ZTS) has just rolled out Lenivia, a long acting monoclonal antibody therapy for canine osteoarthritis pain, offering up to three months of relief from a single injection in Canada and the EU. See our latest analysis for Zoetis. Despite the Lenivia launch and recent vaccine approvals in Europe, Zoetis has been under pressure, with the share price at $76.91 and the year to date share price return down 38.9%, while the 1 year...

BigBear.ai recently expanded its generative AI platform for Department of War mission teams, adding new air-gapped hardware, flexible tenant setups, and both cloud-connected and fully local deployment options across classified environments. A key shift is the move from the Ask Sage brand to a refactored, model-agnostic BigBear.ai platform that lets agencies separate secure workspace licensing from their own “bring-your-own-model” procurement. Now we’ll examine how the new air-gapped,...

Lower fertilizer tariffs, potential trade policy shifts and closer regulatory attention on industry giants are reshaping the playing field for U.S. agricultural producers. For investors, that mix of lower input costs and fresh policy uncertainty can create both opportunity and risk across related stocks. This article focuses on three U.S. Agricultural Producers screener stocks that are directly exposed to the latest fertilizer and trade headlines, and explains how these developments might...

ASP Isotopes Inc. recently filed a shelf registration statement to issue up to US$106.08 million of common stock, covering 23,160,682 shares. This sizeable shelf registration gives the company flexibility to access equity capital quickly, which could shape how investors view its future financing plans. We will now examine how this sizeable shelf registration shapes ASP Isotopes' investment narrative and what it may imply for future capital needs. The future of work is here. Discover the 32...

Main Street Capital recently reported preliminary second-quarter 2026 results showing favorable distributable net investment income and its sixteenth consecutive quarterly increase in net asset value per share, driven primarily by fair value gains in its lower middle market and private loan portfolios. At the same time, analysts are increasingly cautious as income growth slows and management continues to raise regular and supplemental dividends, sharpening questions about the balance between...

Cybin, operating as Helus Pharma, has advanced its lead psychedelic candidate HLP003 into an ongoing Phase 3 trial for adjunctive treatment of major depressive disorder and recently raised about US$50,000,000 in an underwritten public offering to support its development programs. This combination of late-stage clinical progress and fresh funding highlights how Cybin is positioning HLP003 within the evolving landscape of interventional psychiatry for depression care. We’ll now explore how the...

Etsy stock has staged a sharp recovery in the last year, yet its longer term shareholders are still sitting on a steep decline, and the valuation checks are sending mixed messages as the Discounted Cash Flow (DCF) intrinsic value estimate points to a discount while earnings based multiples lean expensive. Over 5 years, Etsy shares have declined 58.6%, which frames the current price against a much weaker long term return profile for existing holders. The approved sale of Depop to eBay for...

Cintas (CTAS) has wrapped up FY 2026 with fourth quarter revenue of US$2.9 billion and basic EPS of US$1.28, supported by trailing 12 month revenue of US$11.3 billion and basic EPS of US$4.98 that reflects earnings growth of about 10.7% over the past year. Over recent periods, the company has seen quarterly revenue move from US$2.67 billion in Q4 FY 2025 to US$2.91 billion in Q4 FY 2026, while basic EPS rose from US$1.11 to US$1.28. Those top line and per share gains are backed by a modest...